We are thrilled to announce that CanPath has been awarded $1.9million in funding from the COVID-19 Immunity Task Force for a COVID-19 seroprevalence study! This work will be implemented by all the regional CanPath cohorts, including Atlantic PATH.
CanPath CITF Funding Announcement_FINAL_ENG